Efficacy and safety of atezolizumab concurrent with radiotherapy in patients with muscle-invasive bladder cancer: An interim analysis of the atezobladderpreserve phase II trial (SOGUG-2017-A-IEC(VEJ)-4)

被引：0
|
作者：
Calvo, Ovidio Fernandez
Bonfill, Teresa
Madueno, Francisca Martinez
Romero-Laorden, Nuria
Sequero-Lopez, Silvia
Domenech-Santasusana, Montserrat
Sevillano, Elena
Sanchez, Jose Garcia
Roman, Pilar Canoa
Alvarez-Fernandez, Carlos
Vazquez-Estevez, Sergio
机构：
[1] Complejo Hosp Univ Ourense, Med Oncol Dept, Orense, Spain
[2] Hosp Univ Parc Tauli, Sabadell, Spain
[3] HU St Joan Reus, Reus, Spain
[4] Hosp Univ Princesa, Madrid, Spain
[5] Hosp Univ San Cecilio, Granada, Spain
[6] Fundacio Althaia, Dept Med Oncol, Barcelona, Spain
[7] Fundacio Althaia, Dept Med Oncol, Manresa, Spain
[8] HM Sanchinarro Ctr Integral Oncol Clara CIOCC, Madrid, Spain
[9] Hosp Arnau Vilanova Valencia, Valencia, Spain
[10] Hosp Univ Lucus Augusti, Lugo, Spain
[11] Hosp Univ Cent Asturias, Med Oncol Dept, Oviedo, Spain
[12] Hosp Univ Lucus Augusti HULA, EOXI Lugo, Lugo, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4592
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial
    Valérie Fonteyne
    Piet Dirix
    Sara Junius
    Elke Rammant
    Piet Ost
    Gert De Meerleer
    Martijn Swimberghe
    Karel Decaestecker
    BMC Cancer, 17
  • [22] Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial
    Fonteyne, Valerie
    Dirix, Piet
    Junius, Sara
    Rammant, Elke
    Ost, Piet
    De Meerleer, Gert
    Swimberghe, Martijn
    Decaestecker, Karel
    BMC CANCER, 2017, 17
  • [23] Adjuvant Radiotherapy After Radical Cystectomy for Patients with High-risk Muscle-invasive Bladder Cancer: Results of a Multicentric Phase II Trial
    Fonteyne, Valerie
    Dirix, P.
    Van Praet, C.
    Berghen, C.
    Albersen, M.
    Junius, S.
    Liefhooghe, N.
    Noe, L.
    De Meerleer, G.
    Ost, P.
    Villeirs, G.
    Verbeke, S.
    De Maeseneer, D.
    Rammant, E.
    Verghote, F.
    Elhaseen, E.
    De Man, K.
    Decaestecker, K.
    EUROPEAN UROLOGY FOCUS, 2022, 8 (05): : 1238 - 1245
  • [24] Neoadjuvant Chemoradiotherapy Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer: Analysis of Efficacy and Safety in 119 Patients
    Fujiwara, Motohiro
    Tanaka, Hajime
    Kobayashi, Masaki
    Nakamura, Yuki
    Fan, Bo
    Ishikawa, Yudai
    Fukuda, Shohei
    Toda, Kazuma
    Yoshida, Soichiro
    Yokoyama, Minato
    Yoshimura, Ryoichi
    Fujii, Yasuhisa
    CLINICAL GENITOURINARY CANCER, 2024, 22 (02) : 193 - 200.e1
  • [25] Pembrolizumab with chemoradiotherapy as treatment for muscle invasive bladder cancer: A planned interim analysis of safety and efficacy of the PCR-MIB phase II clinical trial (ANZUP 1502)
    Weickhardt, Andrew James
    Foroudi, Farshad
    Lawrentschuk, Nathan
    Galleta, Laura
    Seegum, Amanda
    Herschtal, Alan
    Link, Emma
    McJannett, Margaret Mary
    Liow, Elizabeth Chien Hern
    Grimison, Peter S.
    Zhang, Alison Yan
    Patanjali, Nitya
    Ng, Siobhan
    Goodwin, Robert
    Tang, Colin
    Chen, Colin
    Hovey, Elizabeth J.
    Hruby, George
    Guminski, Alexander David
    Davis, Ian D.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [26] Phase I/II trial of cetuximab with 5-fluorouracil and mitomycin C concurrent with radiotherapy in patients with muscle invasive bladder cancer.
    Hussain, Syed A.
    Buckley, Laura
    Kaur, Baljit
    Hendron, Carey
    Zarkar, Anjali
    Ford, Daniel
    Viney, Richard
    Syndikus, Isabel
    Malik, Zafar
    Eswar, Chinnamani
    Desai, Amisha
    Southgate, Elizabeth
    Mangar, Stephen
    Van Der Voet, Johannes
    Lydon, Anna
    James, Nicholas D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [27] Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)
    Weickhardt, Andrew
    Foroudi, Farshad
    Lawrentschuk, Nathan
    Xie, Jing
    Sidhom, Mark
    Pal, Abhijit
    Grimison, Peter
    Zhang, Alison
    Ng, Siobhan
    Tang, Colin
    Hovey, Elizabeth
    Chen, Colin
    Hruby, George
    Guminski, Alexander
    McJannett, Margaret
    Conduit, Ciara
    Tran, Ben
    Davis, Ian D.
    Hayne, Dickon
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (03): : 469 - 477
  • [28] phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in non-urothelial, muscle invasive bladder cancer (ABACUS-2)
    Szabados, B. E.
    Nogueron Martinez, E.
    Alvarez Marquez, F. J.
    Castellano Gauna, D. E.
    Rodriguez-Vida, A.
    Garcias de Espana, M. C.
    Hussain, S. A.
    Alvarez Fernandez, C.
    Linch, M.
    Bonfill Abella, T.
    Goupil, M. Gross
    Kelly, J.
    Jones, R. J.
    Crabb, S.
    Beltran, L.
    Garonce-Hediger, R.
    Rakebrandt, N. J.
    Georgescu, R.
    Ackerman, C.
    Powles, T. B.
    ANNALS OF ONCOLOGY, 2023, 34 : S1201 - S1202
  • [29] Phase II trial of neoadjuvant gemcitabine (G) and cisplatin (C) with sunitinib in patients (pts) with muscle-invasive bladder cancer (MIBC)
    Balar, Arjun Vasant
    Iyer, Gopa
    Apolo, Andrea Borghese
    Regazzi, Ashley Marie
    Garcia-Grossman, Ilana Rebecca
    Pendse, Deepa
    Ostrovnaya, Irina
    Chou, Joanne F.
    Bochner, Bernard
    Dalbagni, Guido
    Herr, Harry W.
    Milowsky, Matthew I.
    Bajorin, Dean F.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] A phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: clinical and pathological results
    Pruthi, Raj S.
    Nielsen, Matthew
    Heathcote, Samuel
    Wallen, Eric M.
    Rathmell, W. Kim
    Godley, Paul
    Whang, Young
    Fielding, Julia
    Schultz, Heather
    Grigson, Gayle
    Smith, Angela
    Kim, William
    O'Donnell, Peter H.
    BJU INTERNATIONAL, 2010, 106 (03) : 349 - 356
12345